首页> 美国卫生研究院文献>Journal of Clinical and Experimental Hepatology >Chemical Analysis of Weight Loss Herbal Supplement Safe Lean™ Associated With Acute Liver Injury – A Concern for Spurious Drug Misbranding and Adulteration
【2h】

Chemical Analysis of Weight Loss Herbal Supplement Safe Lean™ Associated With Acute Liver Injury – A Concern for Spurious Drug Misbranding and Adulteration

机译:与急性肝损伤有关的减肥中草药补充剂Safe Lean™的化学分析–对假药品牌错误和掺假的关注

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Liver injury due to herbal and dietary supplements are well described in literature and its incidence has been on the rise in the past decade. Labelling an herbal product as non-medicinal and as a supplement precludes protocols needed for testing, trials and marketing criteria. This has led to rampant use of clinically unproven multi-herb-based drugs use for a myriad of lifestyle diseases. In this report, we discuss a new dietary weight loss supplement, Safe Lean™ that was found to be the cause of liver injury in a young obese woman, that resolved after discontinuation, and discuss current literature on component, toxicology and chemical analysis of the offending drug.
机译:草药和饮食补充剂引起的肝损伤在文献中已有很好的描述,并且其发病率在过去十年中呈上升趋势。将草药产品标记为非药品和补充品,则排除了测试,试验和营销标准所需的规程。这导致临床上未经证实的基于多种草药的药物被广泛用于多种生活方式疾病。在本报告中,我们讨论了一种新的饮食减肥补充剂Safe Lean™,该补充剂被发现是一名年轻肥胖女性肝损伤的原因,在停药后得以解决,并讨论了有关其成分,毒理学和化学分析的最新文献。冒犯性毒品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号